Loading...
Assessment of soluble cytotoxic T lymphocyte-associated antigen-4, transforming growth factor β(1), and platelet-derived microparticles during dasatinib therapy for patients with chronic myelogenous leukemia
BACKGROUND: The outcome for chronic myelogenous leukemia (CML) patients presented in the chronic phase has changed dramatically since the introduction of tyrosine kinase inhibitor (TKI) therapy. Notably, an increased incidence of large granular lymphocytes (LGLs), which is related to immunological c...
Na minha lista:
| Udgivet i: | J Blood Med |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6305157/ https://ncbi.nlm.nih.gov/pubmed/30588140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S187005 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|